Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-72635-1, published online 16 September 2024
In the original version of this Article, Zhixuan Wu was incorrectly affiliated with ‘The Dingli Clinical College of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China’. The correct affiliation is listed below.
Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang Province 325035, China.
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wu, Z., Guo, Y., Qu, L. et al. Author Correction: Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes. Sci Rep 14, 32176 (2024). https://doi.org/10.1038/s41598-024-83823-4
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-024-83823-4
